Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Sanitizing Products Recalled
02/10/2023
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network
News
Hypertension Drug Recalled
02/10/2023
A prescription calcium-channel blocker is under a Class II recall for failing to meet impurity and dissolution specifications.
A prescription calcium-channel blocker is under a Class II recall for failing to meet impurity and dissolution specifications.
A prescription calcium-channel...
02/10/2023
Pharmacy Learning Network

Advertisement

News
Contaminated OTC Burn Cream Prompts Class I Recall
02/10/2023
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued for burn cream due to microbial contamination.
A Class I recall has been issued...
02/10/2023
Pharmacy Learning Network
News
Online Pharmacy Reaches $18.3 Million Medicaid Fraud Settlement With California
02/08/2023
California authorities claimed the pharmacy prescribed birth control pills without adequate consultation and shipped thousands of products to customers who did not want them.
California authorities claimed the pharmacy prescribed birth control pills without adequate consultation and shipped thousands of products to customers who did not want them.
California authorities claimed...
02/08/2023
First Report Managed Care
News
Will RSV Treatment Be Covered Under Vaccines for Children Program?
02/06/2023
The Centers for Disease Control and Prevention are assessing whether a monoclonal antibody therapy for respiratory syncytial virus should be eligible for federal funding and distribution.
The Centers for Disease Control and Prevention are assessing whether a monoclonal antibody therapy for respiratory syncytial virus should be eligible for federal funding and distribution.
The Centers for Disease Control...
02/06/2023
Pharmacy Learning Network

Advertisement

News
Beta-Blocker Recalled
02/02/2023
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is under a Class II recall for failing to meet dissolution specifications.
A prescription beta-blocker is...
02/02/2023
Pharmacy Learning Network
News
Class I Recall for Antibiotic Injection
02/02/2023
Hospira Inc has recalled thousands of vials of a prescription antibiotic due to the presence of glass particulates.
Hospira Inc has recalled thousands of vials of a prescription antibiotic due to the presence of glass particulates.
Hospira Inc has recalled...
02/02/2023
Pharmacy Learning Network
News
Class I Recall for Advil
02/02/2023
A Class I recall has been issued for several lots of an over-the-counter ibuprofen used for relieving pain and fevers.
A Class I recall has been issued for several lots of an over-the-counter ibuprofen used for relieving pain and fevers.
A Class I recall has been issued...
02/02/2023
Pharmacy Learning Network

Advertisement

News
Montana Pharmacists May Get More Power to Prescribe
01/31/2023
In an effort to close gaps in health care access, a senator in Montana introduced a bill that would expand pharmacists' authority to prescribe medications and devices.
In an effort to close gaps in health care access, a senator in Montana introduced a bill that would expand pharmacists' authority to prescribe medications and devices.
In an effort to close gaps in...
01/31/2023
Pharmacy Learning Network
News
Anesthetic Recalled
01/26/2023
A Class II recall has been issued for more than 100,000 vials of an anesthetic due to subpotency.
A Class II recall has been issued for more than 100,000 vials of an anesthetic due to subpotency.
A Class II recall has been...
01/26/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use